Therapy of spinal muscular atrophy using suberoylanilide hydroxamic acid, a second generation histone deacetylase inhibitor

被引：0

作者：

Hahnen, E ^{[1
]}

Eyüpoglu, IY ^{[1
]}

Brichta, L ^{[1
]}

Haastert, K ^{[1
]}

Tränkle, C ^{[1
]}

Siebzehnrübl, FA ^{[1
]}

Riessland, M ^{[1
]}

Hölker, I ^{[1
]}

Claus, P ^{[1
]}

Romstöck, J ^{[1
]}

Buslei, R ^{[1
]}

Wirth, B ^{[1
]}

Blüumcke, I ^{[1
]}

机构：

[1] Univ Cologne, Inst Humangenet, D-50931 Cologne, Germany

来源：

ACTA NEUROPATHOLOGICA | 2005年 / 110卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：326 / 326

页数：1

共 50 条

[21] Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor
Richon, V. M.
BRITISH JOURNAL OF CANCER, 2006, 95 (Suppl 1) : S2 - S6
[22] Clinical experience with the novel histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid) in patients with relapsed lymphoma
O A O'Connor
British Journal of Cancer, 2006, 95 : S7 - S12
[23] Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo
Butler, LM
Agus, DB
Scher, HI
Higgins, B
Rose, A
Cordon-Cardo, C
Thaler, HT
Rifkind, RA
Marks, PA
Richon, VM
CANCER RESEARCH, 2000, 60 (18) : 5165 - 5170
[24] The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ
Hashioka, Sadayuki
Klegeris, Andis
McGeer, Patrick L.
JOURNAL OF NEUROINFLAMMATION, 2012, 9
[25] In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC)
Usman SF Tambunan
N Bramantya
Arli A Parikesit
BMC Bioinformatics, 12
[26] Cancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitor
V M Richon
British Journal of Cancer, 2006, 95 : S2 - S6
[27] The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines
Leoni, F
Zaliani, A
Bertolini, G
Porro, G
Pagani, P
Pozzi, P
Donà, G
Fossati, G
Sozzani, S
Azam, T
Bufler, P
Fantuzzi, G
Goncharov, I
Kim, SH
Pomerantz, BJ
Reznikov, LL
Siegmund, B
Dinarello, CA
Mascagni, P
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) : 2995 - 3000
[28] Clinical experience with the novel histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid) in patients with relapsed lymphoma
O'Connor, O. A.
BRITISH JOURNAL OF CANCER, 2006, 95 (Suppl 1) : S7 - S12
[29] The histone deacetylase inhibitor suberoylanilide hydroxamic acid attenuates human astrocyte neurotoxicity induced by interferon-γ
Sadayuki Hashioka
Andis Klegeris
Patrick L McGeer
Journal of Neuroinflammation, 9
[30] In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC)
Tambunan, Usman S. F.
Bramantya, N.
Parikesit, Arli A.
BMC BIOINFORMATICS, 2011, 12

← 1 2 3 4 5 →